Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1871 1
1873 1
1877 1
1881 1
1884 1
1890 2
1898 1
1903 1
1904 1
1905 1
1908 1
1909 2
1920 1
1923 2
1926 2
1927 1
1929 1
1932 5
1933 1
1935 1
1936 1
1937 2
1938 4
1942 1
1944 1
1945 8
1946 53
1947 45
1948 47
1949 39
1950 62
1951 74
1952 63
1953 60
1954 68
1955 64
1956 68
1957 87
1958 88
1959 78
1960 97
1961 83
1962 93
1963 155
1964 205
1965 155
1966 163
1967 210
1968 246
1969 193
1970 204
1971 223
1972 224
1973 203
1974 247
1975 254
1976 225
1977 268
1978 237
1979 268
1980 233
1981 287
1982 296
1983 316
1984 395
1985 368
1986 372
1987 330
1988 362
1989 412
1990 451
1991 415
1992 424
1993 381
1994 449
1995 407
1996 425
1997 391
1998 423
1999 436
2000 457
2001 430
2002 482
2003 497
2004 501
2005 609
2006 693
2007 742
2008 803
2009 837
2010 892
2011 927
2012 939
2013 971
2014 931
2015 1013
2016 1086
2017 1059
2018 1195
2019 1222
2020 1337
2021 1364
2022 1252
2023 1230
2024 429

Text availability

Article attribute

Article type

Publication date

Search Results

5,544 results

Results by year

Filters applied: in the last 5 years. Clear all
Page 1
Pathophysiology of systemic sclerosis (scleroderma).
Rosendahl AH, Schönborn K, Krieg T. Rosendahl AH, et al. Kaohsiung J Med Sci. 2022 Mar;38(3):187-195. doi: 10.1002/kjm2.12505. Epub 2022 Mar 2. Kaohsiung J Med Sci. 2022. PMID: 35234358 Free article. Review.
Systemic sclerosis (scleroderma) is an autoimmune-triggered chronic fibrosing disease that affects the skin and many other organs. ...
Systemic sclerosis (scleroderma) is an autoimmune-triggered chronic fibrosing disease that affects the skin and many other org …
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M, Wu J, Wu H, Sawalha AH, Lu Q. Zhao M, et al. Clin Rev Allergy Immunol. 2022 Apr;62(2):273-291. doi: 10.1007/s12016-020-08831-4. Epub 2021 Jan 15. Clin Rev Allergy Immunol. 2022. PMID: 33449302 Review.
There are two major clinical subsets of scleroderma: (i) systemic sclerosis (SSc) is a complex systemic autoimmune disorder characterized by inflammation, vasculopathy, and excessive fibrosis of the skin and multiple internal organs and (ii) localized …
There are two major clinical subsets of scleroderma: (i) systemic sclerosis (SSc) is a complex systemic autoimmune diso …
Scleroderma epidemiology update.
Calderon LM, Pope JE. Calderon LM, et al. Curr Opin Rheumatol. 2021 Mar 1;33(2):122-127. doi: 10.1097/BOR.0000000000000785. Curr Opin Rheumatol. 2021. PMID: 33481429 Review.
PURPOSE OF REVIEW: Systemic sclerosis (scleroderma, SSc) is a rare multisystem autoimmune disease characterized by autoantibodies, vasculopathy, and fibrosis of the skin and internal organs. This review aims to provide an overview and summary of the recent epidemiol …
PURPOSE OF REVIEW: Systemic sclerosis (scleroderma, SSc) is a rare multisystem autoimmune disease characterized by autoantibod …
Drug-induced scleroderma-like lesion.
Hamaguchi Y. Hamaguchi Y. Allergol Int. 2022 Apr;71(2):163-168. doi: 10.1016/j.alit.2021.08.005. Epub 2021 Aug 28. Allergol Int. 2022. PMID: 34465533 Free article. Review.
Drug-induced scleroderma-like lesion is a condition in which administration of a drug induces skin sclerotic lesions similar to systemic sclerosis or morphea. The clinical manifestations of drug-induced scleroderma-like lesion can be divided into two types: …
Drug-induced scleroderma-like lesion is a condition in which administration of a drug induces skin sclerotic lesions similar to sy …
Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
Cole A, Ong VH, Denton CP. Cole A, et al. Clin Rev Allergy Immunol. 2023 Jun;64(3):378-391. doi: 10.1007/s12016-022-08945-x. Epub 2022 Jun 1. Clin Rev Allergy Immunol. 2023. PMID: 35648373 Free PMC article. Review.
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 months. Once the leading cause of mortality in scleroderma (SSc), it remains a serious complication, often necessitating level three car …
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 mon …
Localized scleroderma: actual insights and new biomarkers.
Snarskaya ES, Vasileva KD. Snarskaya ES, et al. Int J Dermatol. 2022 Jun;61(6):667-674. doi: 10.1111/ijd.15811. Epub 2021 Aug 4. Int J Dermatol. 2022. PMID: 34347884 Review.
Localized scleroderma (LS, morphea, limited scleroderma, focal scleroderma) is a chronic autoimmune disease characterized by a progressive damage to the connective tissue with a predominance of fibrosclerotic disorders in the skin and the subcutaneous …
Localized scleroderma (LS, morphea, limited scleroderma, focal scleroderma) is a chronic autoimmune disease char …
Scleroderma of the Hand: Evaluation and Treatment.
Beldner S, Rabinovich RV, Polatsch DB. Beldner S, et al. J Am Acad Orthop Surg. 2020 Aug 15;28(16):e686-e695. doi: 10.5435/JAAOS-D-19-00547. J Am Acad Orthop Surg. 2020. PMID: 32769717 Review.
Scleroderma involves a spectrum of pathologic changes and anatomic involvement. It can be divided into localized and systemic scleroderma. Hand involvement is common and can include calcium deposits within the soft tissues, digital ischemia, and joint …
Scleroderma involves a spectrum of pathologic changes and anatomic involvement. It can be divided into localized and system …
Treatment in Juvenile Scleroderma.
Zulian F, Tirelli F. Zulian F, et al. Curr Rheumatol Rep. 2020 Jun 26;22(8):45. doi: 10.1007/s11926-020-00910-x. Curr Rheumatol Rep. 2020. PMID: 32591919 Review.
PURPOSE OF REVIEW: Treatment of scleroderma in children is challenging since little is known about its pathogenesis. Herein, we review the most recent evidence regarding the treatment of juvenile scleroderma. RECENT FINDINGS: According to the recent recommendations …
PURPOSE OF REVIEW: Treatment of scleroderma in children is challenging since little is known about its pathogenesis. Herein, we revie …
[Juvenile localized scleroderma].
Strauss T, Günther C, Brück N. Strauss T, et al. Dermatologie (Heidelb). 2024 Mar;75(3):208-213. doi: 10.1007/s00105-023-05293-5. Epub 2024 Jan 19. Dermatologie (Heidelb). 2024. PMID: 38240812 Review. German.
Juvenile scleroderma, often referred to as juvenile localized scleroderma or "morphea", is a rare inflammatory disease of the skin and skin-related structures, accompanied by local sclerosis and tissue fibrosis. ...In this review, we present the main clinical …
Juvenile scleroderma, often referred to as juvenile localized scleroderma or "morphea", is a rare inflammatory disease …
Systemic therapy in juvenile localized scleroderma.
Foeldvari I, Marrani E. Foeldvari I, et al. Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1225-1238. doi: 10.1080/1744666X.2023.2237685. Epub 2023 Jul 26. Expert Rev Clin Immunol. 2023. PMID: 37462119 Review.
INTRODUCTION: Juvenile localized scleroderma (JLS) is a rare sclerosing disorder of childhood which can result in permanent morbidity and functional disability, if not effectively treated. ...Patients should be treated in the 'therapeutic window,' before significant …
INTRODUCTION: Juvenile localized scleroderma (JLS) is a rare sclerosing disorder of childhood which can result in permanent mo …
5,544 results

Searches related to "scleroderma"